BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34091453)

  • 1. Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.
    Querfeld C; Scarisbrick JJ; Assaf C; Guenova E; Bagot M; Ortiz-Romero PL; Quaglino P; Bonizzoni E; Hodak E
    Dermatology; 2022; 238(2):347-357. PubMed ID: 34091453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data.
    Querfeld C; Scarisbrick JJ; Assaf C; Kim YH; Guitart J; Quaglino P; Hodak E
    Am J Clin Dermatol; 2022 Jul; 23(4):561-570. PubMed ID: 35536441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
    Kim EJ; Guitart J; Querfeld C; Girardi M; Musiek A; Akilov OE; Angello JT; Bailey WL; Geskin LJ
    Am J Clin Dermatol; 2021 May; 22(3):407-414. PubMed ID: 33656660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Treatment Patterns of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: By-time Reanalysis of a Randomized Controlled Phase 2 Study.
    Geskin LJ; Kim EJ; Angello JT; Kim YH
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):119-124.e4. PubMed ID: 33358692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
    Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
    JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlormethine Gel for the Treatment of Mycosis Fungoides (Cutaneous T-cell Lymphoma) in Canada.
    Gniadecki R; Paron E
    Skin Therapy Lett; 2023 Mar; 28(2):1-5. PubMed ID: 37054720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience.
    Garcia-Saleem TJ; Stonesifer CJ; Khaleel AE; Geskin LJ
    Acta Derm Venereol; 2021 Sep; 101(9):adv00544. PubMed ID: 34436621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences.
    Geskin LJ; Angello JT; Bagot M; Guenova E; Nikbakht N; Querfeld C; Scarisbrick JJ
    Clin Lymphoma Myeloma Leuk; 2024 Jan; 24(1):40-47. PubMed ID: 37802679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlormethine Gel is Efficient and Safe in Mycosis Fungoides Skin Lesions.
    Koumourtzis M; Lampadaki K; Dalamaga M; Papadavid E
    Acta Derm Venereol; 2022 Jun; 102():adv00730. PubMed ID: 35199177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study.
    Correia E; Krishnasamy S; Suriano JG; Shi W; Alpdogan SO; Sahu J; Porcu P; Nikbakht N
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):581-588. PubMed ID: 35393251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports.
    Lampadaki K; Koumourtzis M; Karagianni F; Marinos L; Papadavid E
    Adv Ther; 2021 Jun; 38(6):3455-3464. PubMed ID: 33928511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings.
    Wehkamp U; Ardigò M; Papadavid E; Querfeld C; Nikbakht N
    Adv Ther; 2022 Sep; 39(9):3979-4002. PubMed ID: 35852707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlormethine gel is effective for the treatment of skin lesions in patients with early- and late-stage mycosis fungoides in clinical practice.
    Papadavid E; Koumourtzis M; Nikolaou V; Lampadaki K; Marinos L; Patsatsi A; Georgiou E; Dalamaga M; Stratigos A
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1751-1757. PubMed ID: 35470483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides.
    Alexander-Savino CV; Chung CG; Gilmore ES; Carroll SM; Poligone B
    Dermatol Ther (Heidelb); 2022 Mar; 12(3):643-654. PubMed ID: 35122614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
    Talpur R; Venkatarajan S; Duvic M
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects
    Prag Naveh H; Amitay-Laish I; Zidan O; Leshem YA; Sherman S; Noyman Y; Taieb J; Didkovsky E; Hodak E
    J Dermatolog Treat; 2022 Jun; 33(4):2364-2370. PubMed ID: 34427536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region).
    Assaf C; Booken N; Dippel E; Guenova E; Jonak C; Klemke CD; Nicolay JP; Schlaak M; Wobser M; Trautinger F
    J Dtsch Dermatol Ges; 2022 May; 20(5):579-586. PubMed ID: 35429108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
    Kim EJ; Mangold AR; DeSimone JA; Wong HK; Seminario-Vidal L; Guitart J; Appel J; Geskin L; Lain E; Korman NJ; Zeitouni N; Nikbakht N; Dawes K; Akilov O; Carter J; Shinohara M; Kuzel TM; Piette W; Bhatia N; Musiek A; Pariser D; Kim YH; Elston D; Boh E; Duvic M; Huen A; Pacheco T; Zwerner JP; Lee ST; Girardi M; Querfeld C; Bohjanen K; Olsen E; Wood GS; Rumage A; Donini O; Haulenbeek A; Schaber CJ; Straube R; Pullion C; Rook AH; Poligone B
    JAMA Dermatol; 2022 Sep; 158(9):1031-1039. PubMed ID: 35857290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study.
    Querfeld C; Nelson WW; Gor D; Pashos CL; Doan QV; Turini M; Angello JT; Geskin LJ
    Dermatol Ther (Heidelb); 2022 Dec; 12(12):2781-2795. PubMed ID: 36284059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.
    Geskin LJ; Bagot M; Hodak E; Kim EJ
    Dermatol Ther (Heidelb); 2021 Aug; 11(4):1085-1106. PubMed ID: 34021485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.